There’s no question it has been a rough few months for biotech investors. In a new report, RBC Capital Markets analyst Michael Yee looked at whether the biotech sector has endured similar selloffs in the past.

According to Yee, the biotech sector has dropped below its current forward PE multiple of 14x down to about 13x two times in the past 14 years: during the 2008 Financial Crisis and when President Obama was making changes to the healthcare system.

“So, in our view, today’s valuations already price in a pretty negative outlook and we believe we could be near the trough (perhaps 10 percent or 1 P/E turn and consistent w/ DCF’s around 10 percent to “no pipeline’ levels and there is not a crisis like 2008 and no changes to the HC system at this time),” Yee explained.

Despite the optimism, Yee acknowledged…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!